医学論文のデータベースとしてPubMed(Medline)、Embase、医学中央雑誌などがあり、文献検索はこれらのウェブサイトに接続し、検索式を送信することで、結果を手元に得られる。また、Google、Google ScholarあるいはBingのようなインターネット検索サービスも科学論文を対象にしており、上記の医学文献データベースを介さず検索することも可能である。また、Cochrane Central Register of Controlled Trials (CENTRAL)はランダム化比較試験の研究論文を検索する際には必要となる。
Schmid P, Rugo HS, Adams S, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Henschel V, Molinero L, Chui SY, Maiya V, Husain A, Winer EP, Loi S, Emens LA; IMpassion130 Investigators. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 Jan;21(1):44-59. doi: 10.1016/S1470-2045(19)30689-8. Epub 2019 Nov 27.
Schmid P, et al: Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 Jan;21(1):44-59. doi: 10.1016/S1470-2045(19)30689-8. Epub 2019 Nov 27.
Stellon AJ, Hegarty JE, Portmann B, Williams R. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Lancet. 1985 Mar 23;1(8430):668-70. doi: 10.1016/s0140-6736(85)91329-7. PMID: 2858619.
AMA
Stellon AJ, Hegarty JE, Portmann B, Williams R. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Lancet. 1985 Mar 23;1(8430):668-70. doi: 10.1016/s0140-6736(85)91329-7. PMID: 2858619.
APA
Stellon, A. J., Hegarty, J. E., Portmann, B., & Williams, R. (1985). Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Lancet (London, England), 1(8430), 668–670. https://doi.org/10.1016/s0140-6736(85)91329-7
MLA
Stellon, A J et al. “Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.” Lancet (London, England) vol. 1,8430 (1985): 668-70. doi:10.1016/s0140-6736(85)91329-7
NLM
Stellon AJ, Hegarty JE, Portmann B, Williams R. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Lancet. 1985 Mar 23;1(8430):668-70. doi: 10.1016/s0140-6736(85)91329-7. PMID: 2858619.
検索式1: (sars-cov-2 OR covid-19 OR “new coronavirus” OR “novel coronavirus”) AND 2019:2020[dp] AND humans[mh] AND (english[la] OR japanese[la]) AND “loattrfree full text”[sb] または 検索式2: (sars-cov-2 OR covid-19 OR “new coronavirus” OR “novel coronavirus”) AND 2019:2020[dp] AND humans[mh] AND (english[la] OR japanese[la])
検索式3: (sars-cov-2 OR covid-19 OR “new coronavirus” OR “novel coronavirus”) AND 2019:2020[dp] AND (english[la] OR japanese[la]) AND “loattrfree full text”[sb] または 検索式4: (sars-cov-2 OR covid-19 OR “new coronavirus” OR “novel coronavirus”) AND 2019:2020[dp] AND (english[la] OR japanese[la]) または 検索式5:sars-cov-2 OR covid-19 OR “new coronavirus” OR “novel coronavirus”
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, Han Y, Hu B, Hu F, Li BH, Li YR, Liang K, Lin LK, Luo LS, Ma J, Ma LL, Peng ZY, Pan YB, Pan ZY, Ren XQ, Sun HM, Wang Y, Wang YY, Weng H, Wei CJ, Wu DF, Xia J, Xiong Y, Xu HB, Yao XM, Yuan YF, Ye TS, Zhang XC, Zhang YW, Zhang YG, Zhang HM, Zhao Y, Zhao MJ, Zi H, Zeng XT, Wang YY, Wang XH; , for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020 Feb 6;7(1):4. doi: 10.1186/s40779-020-0233-6. PMID: 32029004; PMCID: PMC7003341.
PubMedを開くとCenters for Disease Control and Prevention (CDC)のCoronavirus (COVID-19)に関するページへのリンクとNational Institutes of Health (NIH)のCoronavirus (COVID-19)の研究に関するページへのリンクが表示されます。